Basic Information
Basic information for AL078590.2-202-14aa
Peptide Name AL078590.2-202-14aa
Genome Position chr6:134525423-134525464[-]
Species Human
Peptide Sequence MGDPVKCFRALEIC
Peptide Length 14
Unique No (AL078590.2-214-14aa,AL078590.2-203-14aa,AL078590.2-205-14aa,AL078590.2-209-14aa,AL078590.2-201-14aa,AL078590.2-215-14aa,AL078590.2-212-14aa,AL078590.2-204-14aa,AL078590.2-211-14aa,AL078590.2-213-14aa,AL078590.2-208-14aa,AL078590.2-207-14aa)
Grand Average of Hydropathicity 0.4714
Relative Molecular Mass 1816.12
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000232310;AL078590.2
Transcript ID/Name ENST00000668477;AL078590.2-202
Transcript Length 1287
Coding Ability 0.1865
DNA Sequence Corresponding to Peptide ATGGGGGACCCAGTGAAGTGCTTCAGAGCCCTAGAGATTTGC
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :